Frank Baehner

Frank Baehner, Dr. is an experienced clinical development leader with a focus on infectious diseases and vaccine development. Currently serving as Senior Clinical Program Lead for Global Clinical Development at BioNTech SE since May 2023, Baehner has a robust background that includes roles such as Global Asset Evidence Lead and Senior Clinical Program Lead at Boehringer Ingelheim and Vice President at CureVac AG. Previous positions include Senior Medical Director at Takeda and Medical Director at Novartis, where notable contributions include leading the clinical development of Takeda's Norovirus vaccine candidate. Baehner possesses a Doctor of Medicine degree from Johannes Gutenberg University Mainz and further qualifications in Advanced Vaccinology from the University of Geneva and executive education from Harvard Medical School. Early in the career, Baehner worked as a paramedic and gained experience in clinical development and medical affairs.